Buy deal — Isomorphic Labs
BuyLive
- Filled
- Sign in to view
- Bid price
- Sign in to view
- Implied valuation
- Sign in to view
- Min ticket
- USD 5,000,000
Terms
- Last-round price
- Sign in to view
- vs last round
- Sign in to view
- Target close
- 22 Dec 2026
- Structure
- SPV1 layer
- Transfer approval
- Company approval pending
- Fees
- Sign in to view
- Information rights
- Sign in to view
Investment thesis
Buy order for $5M of Isomorphic Labs. Alphabet's AI drug discovery spinout, priced at ~$17.5B in the $2.1B Series B (May 2026); new round talks reported at $40-50B.
Sign in to read the full thesisCompany, why now, terms and fees. Free account, approved manually.
Company context
- Thrive Capital
- Alphabet
- GV
- MGX
- Temasek
- CapitalG
- UK Sovereign AI Fund
Documents
Sign in to check document availabilityTimeline
- Opened · 23 Oct 2026
- Funding deadline · 22 Dec 2026
- Target close · 22 Dec 2026Interest window; indications are reviewed as they arrive.
- Estimated settlementSign in to check settlement details.
Process & counterparty
- Our role
- Introducer
- Buyer type
- Sign in to view
Typical transaction process
General guidance, not this offer’s progress. The desk confirms the steps and timing for each transaction.
- Interest
- Desk review and follow-up
- KYC / accreditation
- Documents
- Funding
- Company approval / ROFR
- Settlement
Risks & important information
Structure and fee details are available to signed-in users. Sign in to read deal-specific risks
Indicative, non-binding. Private securities are illiquid and risky.
Other offers
| Company | Side | Min ticket | Price / share | Valuation | Action |
|---|---|---|---|---|---|
| BUY | $5M | Sign in | Sign in | View offer | |
| BUY | $5M | Sign in | Sign in | View offer | |
| BUY | $5M | Sign in | Sign in | View offer |
